AIG-18

N/A

Report date: 2026/03/11 20:02:12

NME

Base Information

Drug NameAIG-18

Drug Alias NameAIG-18AIG18

ClassificationOther

Mechanisms of ActionN6-adenosine-methyltransferase catalytic subunit inhibitors

TargetsN6-adenosine-methyltransferase catalytic subunit

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAIGEN Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A